Nisin ZP, a bacteriocin and food preservative, inhibits head and neck cancer tumorigenesis and prolongs survival

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Kamarajan, Pachiyappan ^a   Hayami, Takayuki ^a   Matte, Bibiana ^a   Liu, Yang ^a   Danciu, Theodora ^a   Ramamoorthy, Ayyalusamy ^b   Worden, Francis ^c   Kapila, Sunil ^a   Kapila, Yvonne ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CASPASE 8; NISIN; NISIN ZP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CANCER SURVIVAL; CAPILLARY DENSITY; CELL PROLIFERATION; CLONOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MOUSE; MOUTH CANCER; NONHUMAN; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; DOSE RESPONSE; DRUG EFFECTS; EXPERIMENTAL NEOPLASM; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; MICROVASCULATURE; MOUTH NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NUDE MOUSE; TUMOR CELL LINE; WESTERN BLOTTING;

MUS;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, NUDE; MICROVESSELS; MOUTH NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; NISIN;

EID: 84940062289     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131008     Document Type: Article

References (64)

1. Nonzee NJ, Dandade NA, Patel U, Markossian T, Agulnik M, Argiris A, et al. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis: results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer. 2008; 113: 1446-1452. doi: 10.1002/cncr.23714 PMID: 18683883
2. Bsoul SA, Huber MA, Terezhalmy GT. Squamous cell carcinoma of the oral tissues: a comprehensive review for oral healthcare providers. J Contemp Dent Pract. 2005; 6: 1-16.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62: 10-29. doi: 10.3322/caac.20138 PMID: 22237781
4. Farkas-Himsley H, Zhang YS, Yuan M, Musclow CE. Partially purified bacteriocin kills malignant cells by apoptosis: programmed cell death. Cell Mol Biol (Noisy-le-grand). 1992; 38: 643-651.
5. Farkas-Himsley H, Hill R, Rosen B, Arab S, Lingwood CA. The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1. Proc Natl Acad Sci U S A. 1995; 92: 6996-7000. PMID: 7624357
6. Koczulla AR, Bals R. Antimicrobial peptides: current status and therapeutic potential. Drugs. 2003; 63: 389-406. PMID: 12558461
7. Sand SL, Haug TM, Nissen-Meyer J, Sand O. The bacterial peptide pheromone plantaricin A permeabilizes cancerous, but not normal, rat pituitary cells and differentiates between the outer and inner membrane leaflet. J Membr Biol. 2007; 216: 61-71. PMID: 17639368
8. Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta. 2008; 1778: 357-375. PMID: 18078805
9. Joo NE, Ritchie K, Kamarajan P, Miao D, Kapila YL. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 2012; 1: 295-305. doi: 10.1002/cam4.35 PMID: 23342279
10. Brotz H, Sahl HG. New insights into the mechanism of action of lantibiotics-diverse biological effects by binding to the same molecular target. J Antimicrob Chemother. 2000; 46: 1-6.
11. Cleveland J, Montville TJ, Nes IF, Chikindas ML. Bacteriocins: safe, natural antimicrobials for food preservation. Int J Food Microbiol. 2001; 71: 1-20. PMID: 11764886
12. http://www.fda.gov/ucm/groups/fdagovpublic/2fdago/foodsgen/documents/document/ucm266587.pdf5
13. Mungrue IN, Pagnon J, Kohannim O, Gargalovic PS, Lusis AJ. CHAC1/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-ATF3-CHOP cascade. J Immunol. 2009; 182: 466-476. PMID: 19109178
14. Moll GN, Clark J, Chan WC, Bycroft BW, Roberts GC, Konings WN, et al. Role of transmembrane pH gradient and membrane binding in nisin pore formation. J Bacteriol. 1997; 179: 135-140. PMID: 8981990
15. Wiedemann I, Breukink E, van Kraaij C, Kuipers OP, Bierbaum G, de Kruijff B, et al. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem. 2001; 276: 1772-1779. PMID: 11038353
16. Giffard CJ, Ladha S, Mackie AR, Clark DC, Sanders D. Interaction of nisin with planar lipid bilayers monitored by fluorescence recovery after photobleaching. J Membr Biol. 1996; 151: 293-300. PMID: 8661516
17. Eckert RL. Structure, function, and differentiation of the keratinocyte. Physiol Rev. 1989; 69: 1316-1346. PMID: 2678169
18. Gasparoni A, Fonzi L, Schneider GB, Wertz PW, Johnson GK, Squier CA. Comparison of differentiation markers between normal and two squamous cell carcinoma cell lines in culture. Arch Oral Biol. 2004; 49: 653-664. PMID: 15196983
19. Ponec M, Havekes L, Kempenaar J, Lavrijsen S, Vermeer BJ. Defective low-density lipoprotein metabolism in cultured, normal, transformed, and malignant keratinocytes. J Invest Dermatol. 1984; 83: 436-440. PMID: 6209343
20. Ponec M, Kempenaar J, Boonstra J. Regulation of lipid synthesis in relation to keratinocyte differentiation capacity. Biochim Biophys Acta. 1987; 921: 512-521. PMID: 2444262
21. Tertoolen LG, Kempenaar J, Boonstra J, de Laat SW, Ponec M. Lateral mobility of plasma membrane lipids in normal and transformed keratinocytes. Biochem Biophys Res Commun. 1988; 152: 491-496. PMID: 2452631
22. Tripathi P, Kamarajan P, Somashekar BS, MacKinnon N, Chinnaiyan AM, Kapila YL, et al. Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target. Int J Biochem Cell Biol. 2012; 44: 1852-1861. doi: 10.1016/j.biocel.2012.06.025 PMID: 22743333
23. Brenner JC, Graham MP, Kumar B, Saunders LM, Kupfer R, Lyons RH, et al. Genotyping of 73 UM- SCC head and neck squamous cell carcinoma cell lines. Head Neck. 2010; 32: 417-426. doi: 10.1002/ hed.21198 PMID: 19760794
24. Matsumoto K, Horikoshi M, Rikimaru K, Enomoto S. A study of an in vitro model for invasion of oral squamous cell carcinoma. J Oral Pathol Med. 1989; 18: 498-501. PMID: 2607470
25. Mulders JW, Boerrigter IJ, Rollema HS, Siezen RJ, de Vos WM. Identification and characterization of the lantibiotic nisin Z, a natural nisin variant. Eur J Biochem. 1991; 201: 581-584. PMID: 1935953
26. Kantak SS, Kramer RH. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem. 1998; 273: 16953-16961. PMID: 9642258
27. Zhang Y, Lu H, Dazin P, Kapila Y. Squamous cell carcinoma cell aggregates escape suspensioninduced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. J Biol Chem. 2004; 279: 48342-48349. PMID: 15331608
28. Kamarajan P, Alhazzazi TY, Danciu T, D'Silva N J, Verdin E, Kapila YL. Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis. Cancer. 2012; 118: 5800-5810. doi: 10.1002/cncr.27655 PMID: 22674009
29. Kamarajan P, Shin JM, Qian X, Matte B, Zhu JY, Kapila YL. ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC. Cancer Med. 2013; 2: 793-802. doi: 10.1002/cam4.147 PMID: 24403253
30. Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 2005; 5: 12. PMID: 15885144
31. Ponce ML. Tube formation: an in vitro matrigel angiogenesis assay. Methods Mol Biol. 2009; 467: 183-188. doi: 10.1007/978-1-59745-241-0-10 PMID: 19301671
32. Alhazzazi TY, Kamarajan P, Joo N, Huang JY, Verdin E, D'Silva NJ, et al. Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer. 2011; 117: 1670-1678. doi: 10.1002/cncr.25676 PMID: 21472714
33. (https://ncifrederick.cancer.gov/Lasp/Acuc/Frederick/Media/Documents/ACUC42.pdf).
34. Frazer AC, Sharrant M., and Hickman J. R. 1962. The biological effects of food additives. I. Nisin. J Sci Food Agric, 13:32-42.
35. Delves-Broughton J. 2005. Nisin as a food preservative. Food Australia-.
36. (http://www.handary.com/download/product/WhiteNisinAMSDS100152.pdf).
37. Cornut G, Fortin C, Soulieres D. Antineoplastic properties of bacteriocins: revisiting potential active agents. Am J Clin Oncol. 2008; 31: 399-404. doi: 10.1097/COC.0b013e31815e456d PMID: 18846002
38. Lagos R, Tello M, Mercado G, Garcia V, Monasterio O. Antibacterial and antitumorigenic properties of microcin E492, a pore-forming bacteriocin. Curr Pharm Biotechnol. 2009; 10: 74-85. PMID: 19149591
39. Saito H, Watanabe T. Effect of a bacteriocin produced by Mycobacterium smegmatis on growth of cultured tumor and normal cells. Cancer Res. 1979; 39: 5114-5117. PMID: 498138
40. Yates KR, Welsh J, Udegbunam NO, Greenman J, Maraveyas A, Madden LA. Duramycin exhibits antiproliferative properties and induces apoptosis in tumour cells. Blood Coagul Fibrinolysis. 2012; 23: 396-401. doi: 10.1097/MBC.0b013e3283538875 PMID: 22543977
41. Shaikh F, Abhinand P, Ragunath P. Identification & Characterization of lactobacillus salavarius bacteriocins and its relevance in cancer therapeutics. Bioinformation. 2012; 8: 589-594. doi: 10.6026/97320630008589 PMID: 22829737
42. Kaur G, Singh TP, Malik RK. Antibacterial efficacy of Nisin, Pediocin 34 and Enterocin FH99 against Listeria monocytogenes and cross resistance of its bacteriocin resistant variants to common food preservatives. Braz J Microbiol. 2013; 44: 63-71. doi: 10.1590/S1517-83822013005000025 PMID: 24159285
43. You T, Hu W, Ge X, Shen J, Qin X. Application of a novel inhibitor of human CD59 for the enhancement of complement-dependent cytolysis on cancer cells. Cell Mol Immunol. 2011; 8: 157-163. doi: 10. 1038/cmi.2010.35 PMID: 21258360
44. Hu W, Ge X, You T, Xu T, Zhang J, Wu G, et al. Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysis. Cancer Res. 2011; 71: 2298-2307. doi: 10.1158/ 0008-5472.CAN-10-3016 PMID: 21252115
45. Smith A, Blois J, Yuan H, Aikawa E, Ellson C, Figueiredo JL, et al. The antiproliferative cytostatic effects of a self-activating viridin prodrug. Mol Cancer Ther. 2009; 8: 1666-1675. doi: 10.1158/1535-7163. MCT-08-1012 PMID: 19509266
46. Tsugu H, Onishi H, Fukushima T, Lee S. Anti-tumor activity of de novo designed small globular protein (SGP) in vivo. Anticancer Res. 2006; 26: 4043-4046. PMID: 17195455
47. Ihle NT, Williams R, Chow S, Chew W, Berggren MI, Paine-Murrieta G, et al. Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling. Mol Cancer Ther. 2004; 3: 763-772. PMID: 15252137
48. Cao LT, Wu JQ, Xie F, Hu SH, Mo Y. Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows. J Dairy Sci. 2007; 90: 3980-3985. PMID: 17639009
49. Wu J, Hu S, Cao L. Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob Agents Chemother. 2007; 51: 3131-3135. PMID: 17606675
50. Fernandez L, Delgado S, Herrero H, Maldonado A, Rodriguez JM. The bacteriocin nisin, an effective agent for the treatment of staphylococcal mastitis during lactation. J Hum Lact. 2008; 24: 311-316. doi: 10.1177/0890334408317435 PMID: 18689718
51. Bao JJ, Le XF, Wang RY, Yuan J, Wang L, Atkinson EN, et al. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res. 2002; 62: 7264-7272. PMID: 12499268
52. Cui Q, Yu JH, Wu JN, Tashiro S, Onodera S, Minami M, et al. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells. Acta Pharmacol Sin. 2007; 28: 1057-1066. PMID: 17588343
53. Bai X, Kinney WH, Su WL, Bai A, Ovrutsky AR, Honda JR, et al. Caspase-3-independent apoptotic pathways contribute to interleukin-32 gamma-mediated control of Mycobacterium tuberculosis infection in THP-1 cells. Bmc Microbiology. 2015; 15.
54. Yoo JO, Lim YC, Kim YM, Ha KS. Transglutaminase 2 promotes both caspase-dependent and caspase-independent apoptotic cell death via the calpain/Bax protein signaling pathway. J Biol Chem. 2012; 287: 14377-14388. doi: 10.1074/jbc.M111.326074 PMID: 22418443
55. Kang H, Han BS, Kim SJ, Oh YJ. Mechanisms to prevent caspase activation in rotenone-induced dopaminergic neurodegeneration: role of ATP depletion and procaspase-9 degradation. Apoptosis. 2012.
56. Selimovic D, Ahmad M, El-Khattouti A, Hannig M, Haikel Y, Hassan M. Apoptosis-related protein-2 triggers melanoma cell death by a mechanism including both endoplasmic reticulum stress and mitochondrial dysregulation. Carcinogenesis. 2011; 32: 1268-1278. doi: 10.1093/carcin/bgr112 PMID: 21693538
57. Karmakar S, Choudhury SR, Banik NL, Ray SK. Activation of Multiple Molecular Mechanisms for Increasing Apoptosis in Human Glioblastoma T98G Xenograft. J Cancer Sci Ther. 2010; 2: 107-113. PMID: 21666767
58. Diwakarla S, Mercer LD, Kardashsyan L, Chu PW, Shin YS, Lau CL, et al. GABAergic striatal neurons exhibit caspase-independent, mitochondrially mediated programmed cell death. J Neurochem. 2009;109 Suppl 1: 198-206. doi: 10.1111/j.1471-4159.2009.05937.x PMID: 19393028
59. Zhang Y, Bhavnani BR. Glutamate-induced apoptosis in neuronal cells is mediated via caspasedependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. BMC Neurosci. 2006; 7:49. PMID: 16776830
60. Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, et al. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspaseindependent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer. 2005; 115: 74-84. PMID: 15688415
61. Lu JR, Lu WW, Lai JZ, Tsai FL, Wu SH, Lin CW, et al. Calcium flux and calpain-mediated activation of the apoptosis-inducing factor contribute to enterovirus 71-induced apoptosis. J Gen Virol. 2013; 94: 1477-1485. doi: 10.1099/vir.0.047753-0 PMID: 23515028
62. Delavallee L, Cabon L, Galan-Malo P, Lorenzo HK, Susin SA. AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics. IUBMB Life. 2011; 63: 221-232. doi: 10.1002/iub.432 PMID: 21438113
63. Artus C, Maquarre E, Moubarak RS, Delettre C, Jasmin C, Susin SA, et al. CD44 ligation induces caspase-independent cell death via a novel calpain/AIF pathway in human erythroleukemia cells. Oncogene. 2006; 25: 5741-5751. PMID: 16636662
64. Jeong JC, Shin WY, Kim TH, Kwon CH, Kim JH, Kim YK, et al. Silibinin induces apoptosis via calpaindependent AIF nuclear translocation in U87MG human glioma cell death. J Exp Clin Cancer Res. 2011; 30: 44. doi: 10.1186/1756-9966-30-44 PMID: 21501525